AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Introduction
Discussing the approval of CAR T-cell therapy A Bechma in Japan for the treatment of relapsed or refractory multiple myeloma and explaining its mechanism of action and the supporting Phase 3 study data.